Entering text into the input field will update the search result below

Vir Biotechnology GAAP EPS of $3.85 beats by $0.31, revenue of $1.23B beats by $418.95M

May 05, 2022 4:48 PM ETVir Biotechnology, Inc. (VIR) StockBy: Niloofer Shaikh, SA News Editor1 Comment
  • Vir Biotechnology press release (NASDAQ:VIR): Q1 GAAP EPS of $3.85 beats by $0.31.
  • Revenue of $1.23B (+61400.0% Y/Y) beats by $418.95M.
  • Shares +3%.
  • CEO comment: “At our recent Hepatitis Portfolio R&D Day, we shared encouraging initial data from our Phase 2 MARCH

Recommended For You

About VIR Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
VIR--
Vir Biotechnology, Inc.